Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) CEO Leonard S. Schleifer sold 9,064 shares of Regeneron Pharmaceuticals stock in a transaction that occurred on Tuesday, June 11th. The stock was sold at an average price of $1,015.43, for a total transaction of $9,203,857.52. Following the transaction, the chief executive officer now owns 55,134 shares […]
Forefront Analytics LLC purchased a new position in shares of Cogent Biosciences, Inc. (NASDAQ:COGT – Free Report) during the fourth quarter, HoldingsChannel.com reports. The fund purchased 19,982 shares of the technology company’s stock, valued at approximately $117,000. A number of other large investors have also made changes to their positions in COGT. AJOVista LLC acquired […]
Bain Capital Investors LLC lifted its position in Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE – Free Report) by 9.1% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 65,679,781 shares of the biotechnology company’s stock after purchasing an additional 5,480,052 shares during the quarter. […]
MiMedx Group (NASDAQ:MDXG – Get Free Report) was upgraded by research analysts at StockNews.com from a “buy” rating to a “strong-buy” rating in a note issued to investors on Monday. Other equities research analysts have also issued research reports about the stock. Lake Street Capital initiated coverage on shares of MiMedx Group in a research […]
Crestline Management LP raised its position in Travere Therapeutics, Inc. (NASDAQ:TVTX – Free Report) by 32.6% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 81,423 shares of the company’s stock after purchasing an additional 20,002 shares during the quarter. Crestline […]